111 related articles for article (PubMed ID: 1913645)
41. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
42. Hemoglobin-carcinogen adducts as molecular biomarkers in epidemiology.
Tannenbaum SR
Princess Takamatsu Symp; 1990; 21():351-60. PubMed ID: 2134688
[TBL] [Abstract][Full Text] [Related]
43. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers.
Bartsch H; Nair U; Risch A; Rojas M; Wikman H; Alexandrov K
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):3-28. PubMed ID: 10667460
[TBL] [Abstract][Full Text] [Related]
44. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California.
Yu MC; Skipper PL; Taghizadeh K; Tannenbaum SR; Chan KK; Henderson BE; Ross RK
J Natl Cancer Inst; 1994 May; 86(9):712-6. PubMed ID: 8158701
[TBL] [Abstract][Full Text] [Related]
45. Bulky DNA adducts and risk of cancer: a meta-analysis.
Veglia F; Matullo G; Vineis P
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):157-60. PubMed ID: 12582026
[TBL] [Abstract][Full Text] [Related]
46. Molecular dosimetry of aromatic amines in human populations.
Skipper PL; Tannenbaum SR
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):17-21. PubMed ID: 7889842
[TBL] [Abstract][Full Text] [Related]
47. Interindividual variation in carcinogen metabolism and bladder cancer risk.
Vineis P; Ronco G
Environ Health Perspect; 1992 Nov; 98():95-9. PubMed ID: 1486869
[TBL] [Abstract][Full Text] [Related]
48. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.
Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9788-91. PubMed ID: 3200858
[TBL] [Abstract][Full Text] [Related]
49. Analytical methods for assessing exposure to 4-aminobiphenyl based on protein adduct formation.
Skipper PL; Bryant MS; Tannenbaum SR; Groopman JD
J Occup Med; 1986 Aug; 28(8):643-6. PubMed ID: 3746485
[TBL] [Abstract][Full Text] [Related]
50. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers.
Bartsch H; Caporaso N; Coda M; Kadlubar F; Malaveille C; Skipper P; Talaska G; Tannenbaum SR; Vineis P
J Natl Cancer Inst; 1990 Dec; 82(23):1826-31. PubMed ID: 2250298
[TBL] [Abstract][Full Text] [Related]
51. Elevated blood levels of carcinogens in passive smokers.
Maclure M; Katz RB; Bryant MS; Skipper PL; Tannenbaum SR
Am J Public Health; 1989 Oct; 79(10):1381-4. PubMed ID: 2782507
[TBL] [Abstract][Full Text] [Related]
52. Levels of the adducts of 4-aminobiphenyl to hemoglobin in control subjects and bladder carcinoma patients.
Del Santo P; Moneti G; Salvadori M; Saltutti C; Delle Rose A; Dolara P
Cancer Lett; 1991 Dec; 60(3):245-51. PubMed ID: 1756515
[TBL] [Abstract][Full Text] [Related]
53. Bulky DNA adducts, 4-aminobiphenyl-haemoglobin adducts and diet in the European Prospective Investigation into Cancer and Nutrition (EPIC) prospective study.
Peluso M; Airoldi L; Munnia A; Colombi A; Veglia F; Autrup H; Dunning A; Garte S; Gormally E; Malaveille C; Matullo G; Overvad K; Raaschou-Nielsen O; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Palli D; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita BH; Peeters PH; Kumle M; Agudo A; Martinez C; Dorronsoro M; Barricarte A; Tormo MJ; Quiros JR; Berglund G; Jarvholm B; Day NE; Key TJ; Saracci R; Kaaks R; Riboli E; Bingham S; Vineis P
Br J Nutr; 2008 Sep; 100(3):489-95. PubMed ID: 18275627
[TBL] [Abstract][Full Text] [Related]
54. Structure of the single stable hemoglobin adduct formed by 4-aminobiphenyl in vivo.
Ringe D; Turesky RJ; Skipper PL; Tannenbaum SR
Chem Res Toxicol; 1988; 1(1):22-4. PubMed ID: 2979706
[No Abstract] [Full Text] [Related]
55. Elevated 4-aminobiphenyl and 2,6-dimethylaniline hemoglobin adducts and increased risk of bladder cancer among lifelong nonsmokers--The Shanghai Bladder Cancer Study.
Tao L; Day BW; Hu B; Xiang YB; Wang R; Stern MC; Gago-Dominguez M; Cortessis VK; Conti DV; Van Den Berg D; Pike MC; Gao YT; Yu MC; Yuan JM
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):937-45. PubMed ID: 23539508
[TBL] [Abstract][Full Text] [Related]
56. Haemoglobin adducts formed by aromatic amines in smokers: sources of inter-individual variability.
Ronco G; Vineis P; Bryant MS; Skipper PL; Tannenbaum SR
Br J Cancer; 1990 Apr; 61(4):534-7. PubMed ID: 2331440
[TBL] [Abstract][Full Text] [Related]
57. 4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer.
Martone T; Airoldi L; Magagnotti C; Coda R; Randone D; Malaveille C; Avanzi G; Merletti F; Hautefeuille A; Vineis P
Int J Cancer; 1998 Feb; 75(4):512-6. PubMed ID: 9466649
[TBL] [Abstract][Full Text] [Related]
58. Effects of lead on 4-aminobiphenyl pharmacokinetics in liver, kidney, spleen, testes, heart, lung and hemoglobin adduct for rat model.
Chen HM; Qin T; Zhao LX; Xu XB
Ecotoxicology; 2002 Aug; 11(4):255-64. PubMed ID: 12211698
[TBL] [Abstract][Full Text] [Related]
59. Lung cancer and the debrisoquine metabolic phenotype.
Caporaso NE; Tucker MA; Hoover RN; Hayes RB; Pickle LW; Issaq HJ; Muschik GM; Green-Gallo L; Buivys D; Aisner S
J Natl Cancer Inst; 1990 Aug; 82(15):1264-72. PubMed ID: 2374176
[TBL] [Abstract][Full Text] [Related]
60. Molecular Interactions of Carcinogenic Aromatic Amines, 4-Aminobiphenyl and 4,4'-Diaminobiphenyl, with Lactoperoxidase - Insight to Breast Cancer.
Sheikh IA; Beg MA; Yasir M
Anticancer Res; 2017 Nov; 37(11):6245-6249. PubMed ID: 29061807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
